InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
5.48
+0.11 (2.05%)
At close: May 12, 2025, 4:00 PM
5.48
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
InfuSystem Holdings Revenue
InfuSystem Holdings had revenue of $34.72M in the quarter ending March 31, 2025, with 8.50% growth. This brings the company's revenue in the last twelve months to $137.58M, up 7.98% year-over-year. In the year 2024, InfuSystem Holdings had annual revenue of $134.86M with 7.22% growth.
Revenue (ttm)
$137.58M
Revenue Growth
+7.98%
P/S Ratio
0.85
Revenue / Employee
$267,669
Employees
514
Market Cap
114.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 134.86M | 9.08M | 7.22% |
Dec 31, 2023 | 125.79M | 15.87M | 14.44% |
Dec 31, 2022 | 109.91M | 7.53M | 7.36% |
Dec 31, 2021 | 102.38M | 5.79M | 5.99% |
Dec 31, 2020 | 96.60M | 15.52M | 19.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
INFU News
- 2 days ago - InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - InfuSystem Reports First Quarter 2025 Financial Results - Business Wire
- 11 days ago - InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 5 weeks ago - InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer - Business Wire
- 2 months ago - InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024 - Business Wire
- 2 months ago - InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Business Wire
- 3 months ago - InfuSystem Set For Strong Year - Seeking Alpha